Investors / United States / Sofinnova
Sofinnova
Venture capital · Menlo Park, CA, United States · North America
Sofinnova is a healthcare investment firm that invests in private and public equity companies, with a primary focus on therapeutic drugs over the last decade. It invests in late preclinical and clinical therapeutic companies across the U.S. and Europe and has approximately $4.6B in assets under management and committed capital.
Invests inHealthcare & Biotech
In its own wordstherapeuticshealthcarebiotechoncologyneurologywomen's health
Your fit with Sofinnova
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSofinnova lists 44 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (97%) and Fintech (3%). 83% of its companies are based in United States. It invests most often alongside RA Capital, Foresite Capital and NEA.
No funding round on record names Sofinnova yet, so the figures come from its portfolio page.
Round figures show recent activity, not Sofinnova's whole history. Rounds on record name 0 companies; its own site lists 44. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 78th | 42 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 97th | 97% in its largest sector |
| Reach | 84th | 6 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3989%
- No longer answers00%
- Points to another company511%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 97% | 15% |
| Fintech | 3% | 12% |
Co-investor network
who it backs companies with, and who they back togetherCompare Sofinnova head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its sitePortfolio
44 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aeovian Pharmaceuticals develops small molecules to treat certain rare genetic and age-related diseases | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Portfolio page | ||||
Healthcare & Biotech | Portfolio page | |||
| Alkeus Pharmaceuticals develops innovative medicines to preserve sight for people impacted by retinal disease | Healthcare & Biotech | Portfolio page | ||
| The company is dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers. | Healthcare & Biotech | Portfolio page | ||
| Ascendis Pharma is a biopharmaceutical company that develops new therapies using its TransCon technology platform to improve treatment safety, efficacy, tolerability, and convenience. | Healthcare & Biotech | Portfolio page | ||
| aTyr Pharma translates tRNA synthetase biology into new therapies for fibrosis and inflammation | Healthcare & Biotech | Portfolio page | ||
| Avenzo Therapeutics develops next-generation oncology therapies to transform cancer treatment | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| B Capital invests in early to late-stage companies in sectors such as technology, healthcare, and energy and resilience. | Healthcare & BiotechFintech | Portfolio page | ||
| The company is harnessing the biology of human aging to develop new therapies for cardiometabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Bolt Biotherapeutics develops treatments for cancer | Healthcare & Biotech | Portfolio page | ||
| City Therapeutics is a clinical-stage biotechnology company developing the next generation of RNAi therapeutics designed to silence the expression of disease-relevant proteins | Healthcare & Biotech | Portfolio page | ||
| Claris Bio is developing therapies for sight-threatening conditions, including limbal stem cell deficiency | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Expedition Therapeutics is developing novel treatments for inflammatory and respiratory diseases | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page |
About this data
site last read 5 Nov 2026- Site
- sofinnova.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 44
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Sofinnova's profile as data
Pull Sofinnova's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sofinnova.com
# also
GET /v1/firms/sofinnova.com/portfolio
GET /v1/firms/sofinnova.com/coinvestors
GET /v1/firms/sofinnova.com/news